Skip to content
Menu

UBS Maintains Neutral on Molina Healthcare, Raises Price Target to $225

Benzinga Newsdesk 1 month ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

UBS analyst A.J. Rice maintains Molina Healthcare (NYSE:MOH) with a Neutral and raises the price target from $202 to $225.

UBS analyst A.J. Rice maintains Molina Healthcare (NYSE:MOH) with a Neutral and raises the price target from $202 to $225.

Read at benzinga.com

← All stock news